Upgrade Boutique is a managed marketplace that provides beauty products and services. The company connects with consumers that seek custom wigs, extensions, and curated beauty products with a network of stylists and colorists. Upgrade Boutique was founded in 2019 by Britney Winters and is headquartered in Houston, Texas.
Developer of business and tour management software intended for touring entertainers. The company's software offers an all-in-one, mobile solution for event scheduling, coordination and finance tracking, enabling local venues and independent artists to save time as well as stay compliant while managing gig payments.
Buildforce is a developer of a construction labor platform aimed at improving project outcomes in the construction industry. The company offers a labor marketplace that connects skilled tradesmen with construction firms, alongside workforce management and payroll software-as-a-service. This platform enables clients to efficiently identify qualified candidates for their critical projects while providing workers with opportunities to advance their careers. The founding team includes professionals with extensive experience in construction staffing, software engineering, and global market expansion, positioning Buildforce to effectively address the challenges faced by contractors in scaling their workforce without increasing risk and overhead.
Cart.com is an integrated ecommerce platform that supports brands and distributors in enhancing their online operations. The company offers a comprehensive suite of services, including business planning, merchant financing, order fulfillment, and marketing solutions. By providing these tools, Cart.com enables clients to effectively manage their online businesses, fostering growth and improving the fulfillment of customer commitments. This unified approach to commerce and logistics helps businesses of all sizes scale their operations and increase revenue.
Graylog provides service and support for the open source Graylog solution which stores, searches, and analyzes machine data collected from IT infrastructures and applications. The company enables organizations, at a fraction of the cost, to improve IT operations efficiency, security, and reduce the cost of IT. Graylog has received funding from the Mercury Fund and is based in Houston.
Upgrade Boutique is a managed marketplace that provides beauty products and services. The company connects with consumers that seek custom wigs, extensions, and curated beauty products with a network of stylists and colorists. Upgrade Boutique was founded in 2019 by Britney Winters and is headquartered in Houston, Texas.
Molecule Software, Inc. is a developer of energy trading and risk management software based in Houston, Texas, founded in 2012. The company offers a cloud-based platform designed to assist commodity traders, risk managers, and operations teams. Its software, known as Molecule, includes features such as physical inventory support, reconciliation, market data download capabilities, and market data analytics. The platform efficiently integrates trades and position data from various exchanges and spreadsheets, allowing users to quickly calculate position, profit and loss, and value-at-risk. This streamlined approach aims to reduce the time and costs associated with traditional implementations while enhancing data security and reliability. Molecule Software serves various sectors, including electricity, natural gas, NGLs, and crude oil.
Cart.com is an integrated ecommerce platform that supports brands and distributors in enhancing their online operations. The company offers a comprehensive suite of services, including business planning, merchant financing, order fulfillment, and marketing solutions. By providing these tools, Cart.com enables clients to effectively manage their online businesses, fostering growth and improving the fulfillment of customer commitments. This unified approach to commerce and logistics helps businesses of all sizes scale their operations and increase revenue.
Buildforce is a developer of a construction labor platform aimed at improving project outcomes in the construction industry. The company offers a labor marketplace that connects skilled tradesmen with construction firms, alongside workforce management and payroll software-as-a-service. This platform enables clients to efficiently identify qualified candidates for their critical projects while providing workers with opportunities to advance their careers. The founding team includes professionals with extensive experience in construction staffing, software engineering, and global market expansion, positioning Buildforce to effectively address the challenges faced by contractors in scaling their workforce without increasing risk and overhead.
Topl LLC, founded in 2017, is based in Houston, Texas, and specializes in blockchain-as-a-service (BaaS) for supply chain management and certification. The company has developed The Topl Blockchain, which serves as a protocol designed to support ethical and sustainable practices by allowing organizations to track and trace their supply chains comprehensively. This technology enables businesses to verify and monetize their commitment to sustainability and ethical practices. Additionally, Topl provides a suite of hosted services and tools that facilitate user interaction with its blockchain, enhancing accessibility for companies seeking to leverage this technology. By focusing on the impact space, Topl aims to transform ethical practices into tangible assets within the economy.
Topl LLC, founded in 2017, is based in Houston, Texas, and specializes in blockchain-as-a-service (BaaS) for supply chain management and certification. The company has developed The Topl Blockchain, which serves as a protocol designed to support ethical and sustainable practices by allowing organizations to track and trace their supply chains comprehensively. This technology enables businesses to verify and monetize their commitment to sustainability and ethical practices. Additionally, Topl provides a suite of hosted services and tools that facilitate user interaction with its blockchain, enhancing accessibility for companies seeking to leverage this technology. By focusing on the impact space, Topl aims to transform ethical practices into tangible assets within the economy.
Buildforce is a developer of a construction labor platform aimed at improving project outcomes in the construction industry. The company offers a labor marketplace that connects skilled tradesmen with construction firms, alongside workforce management and payroll software-as-a-service. This platform enables clients to efficiently identify qualified candidates for their critical projects while providing workers with opportunities to advance their careers. The founding team includes professionals with extensive experience in construction staffing, software engineering, and global market expansion, positioning Buildforce to effectively address the challenges faced by contractors in scaling their workforce without increasing risk and overhead.
Meshify, Inc. is a Houston-based company that specializes in electronic-device management software for the Internet of Things (IoT) market. Founded in 2012, Meshify provides tools that enable Original Equipment Manufacturers (OEMs) to quickly convert existing devices into internet-connected products. Its software facilitates real-time measurement, monitoring, and control, allowing users to receive alerts via email, text, and mobile applications. The platform also includes features for user and node management, as well as data visualization through graphs and charts. Meshify serves a variety of sectors, including remote tank monitoring, energy management, and insurance, by offering solutions such as sensors for water shutoff and leak detection. The company also supports hardware development services, including board design and wireless integration. As of 2016, Meshify operates as a subsidiary of HSB Group, Inc.
Graylog provides service and support for the open source Graylog solution which stores, searches, and analyzes machine data collected from IT infrastructures and applications. The company enables organizations, at a fraction of the cost, to improve IT operations efficiency, security, and reduce the cost of IT. Graylog has received funding from the Mercury Fund and is based in Houston.
Molecule Software, Inc. is a developer of energy trading and risk management software based in Houston, Texas, founded in 2012. The company offers a cloud-based platform designed to assist commodity traders, risk managers, and operations teams. Its software, known as Molecule, includes features such as physical inventory support, reconciliation, market data download capabilities, and market data analytics. The platform efficiently integrates trades and position data from various exchanges and spreadsheets, allowing users to quickly calculate position, profit and loss, and value-at-risk. This streamlined approach aims to reduce the time and costs associated with traditional implementations while enhancing data security and reliability. Molecule Software serves various sectors, including electricity, natural gas, NGLs, and crude oil.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
SEE Forge Pty Ltd. operates SEE Forge, a cloud-based platform designed to streamline operations by replacing traditional paperwork and spreadsheets. This platform integrates a mobile reporting application with a web-based command center, enabling seamless communication between field operators and executives. It allows users across various industries, including mining, oil and gas, healthcare, construction, energy, and retail, to efficiently collect, report, and manage operational information. By transforming day-to-day activities into reports, SEE Forge enhances productivity, reduces costs, and minimizes risk for organizations. Based in West Perth, Australia, SEE Forge has been recognized for its contributions to mobile technology and enterprise applications.
Apsara Therapeutics is a biopharmaceutical company based in Houston, Texas, that specializes in developing antibody therapies for neuromyelitis optica (NMO), a demyelinating disorder that affects the spinal cord and optic nerve. The company's innovative therapies aim to block the formation of lesions associated with NMO and to interrupt the inflammatory processes that lead to demyelination and neuronal cell death. By focusing on antibody-mediated immune disorders, Apsara Therapeutics is working towards providing effective treatments that address the underlying mechanisms of this debilitating condition.
Apsara Therapeutics is a biopharmaceutical company based in Houston, Texas, that specializes in developing antibody therapies for neuromyelitis optica (NMO), a demyelinating disorder that affects the spinal cord and optic nerve. The company's innovative therapies aim to block the formation of lesions associated with NMO and to interrupt the inflammatory processes that lead to demyelination and neuronal cell death. By focusing on antibody-mediated immune disorders, Apsara Therapeutics is working towards providing effective treatments that address the underlying mechanisms of this debilitating condition.
SEE Forge Pty Ltd. operates SEE Forge, a cloud-based platform designed to streamline operations by replacing traditional paperwork and spreadsheets. This platform integrates a mobile reporting application with a web-based command center, enabling seamless communication between field operators and executives. It allows users across various industries, including mining, oil and gas, healthcare, construction, energy, and retail, to efficiently collect, report, and manage operational information. By transforming day-to-day activities into reports, SEE Forge enhances productivity, reduces costs, and minimizes risk for organizations. Based in West Perth, Australia, SEE Forge has been recognized for its contributions to mobile technology and enterprise applications.
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
Molecule Software, Inc. is a developer of energy trading and risk management software based in Houston, Texas, founded in 2012. The company offers a cloud-based platform designed to assist commodity traders, risk managers, and operations teams. Its software, known as Molecule, includes features such as physical inventory support, reconciliation, market data download capabilities, and market data analytics. The platform efficiently integrates trades and position data from various exchanges and spreadsheets, allowing users to quickly calculate position, profit and loss, and value-at-risk. This streamlined approach aims to reduce the time and costs associated with traditional implementations while enhancing data security and reliability. Molecule Software serves various sectors, including electricity, natural gas, NGLs, and crude oil.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
Molecule Software, Inc. is a developer of energy trading and risk management software based in Houston, Texas, founded in 2012. The company offers a cloud-based platform designed to assist commodity traders, risk managers, and operations teams. Its software, known as Molecule, includes features such as physical inventory support, reconciliation, market data download capabilities, and market data analytics. The platform efficiently integrates trades and position data from various exchanges and spreadsheets, allowing users to quickly calculate position, profit and loss, and value-at-risk. This streamlined approach aims to reduce the time and costs associated with traditional implementations while enhancing data security and reliability. Molecule Software serves various sectors, including electricity, natural gas, NGLs, and crude oil.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.
Glycos Biotechnologies, Inc. is a Houston-based company specializing in food science and biotechnology. Founded in 2007, it focuses on developing personalized nutritional foods aimed at addressing dietary deficiencies associated with various health conditions. Its product offerings include Monomega, a pre-digested form of essential omega-3 fatty acids for cell growth; Monomega-V, which enhances the delivery of essential fatty acids along with vitamins; and Peptide Plus, a plant-based protein hydrolysate tailored for individual gut functions. In addition to its nutritional products, Glycos Biotechnologies collaborates with partners in the fuels and chemicals sectors to facilitate the production of high-value products from non-food feedstocks, helping to enhance profitability and reduce carbon footprints. The company works with ethanol and biodiesel businesses, as well as biorefinery operators, to provide integrated solutions for alternative chemicals and fuels production.
DNAtrix, Inc. is a clinical stage biotechnology company based in Houston, Texas, specializing in virus-driven immunotherapies for cancer treatment. The company develops modified viruses designed to selectively target and kill cancer cells, with its lead product, DNX-2401, focused on glioblastoma, an aggressive and currently incurable brain tumor. This oncolytic immunotherapy has shown promising early results, having been administered to over 35 patients. In addition to DNX-2401, DNAtrix is advancing other therapies, including DNX-2440 and DNX-2450 for solid tumors, and MYX-135 for hematological malignancies. The company aims to expand its platform technology to address a broader range of cancers, including brain metastases, ovarian, and pancreatic cancer. DNAtrix has formed a strategic partnership with Valo Therapeutics to enhance its research and development efforts.